PharmaCyte Biotech, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-3.3M | $-3.3M | — | $420.5K |
| FY2018 | $-5.1M | $-5.1M | — | $580.4K |
| FY2019 | $-2.9M | $-2.9M | — | $293.3K |
| FY2020 | $-2.3M | $-2.3M | — | $368.7K |
| FY2021 | $-3.3M | $-3.3M | — | $194.3K |
| FY2022 | $-4.1M | $-4.1M | — | $33.1K |
| FY2023 | $-3.8M | $-3.8M | — | $7.3K |
| FY2024 | $-2.2M | $-2.2M | — | $674.7K |
| FY2025 | $-3.0M | $-3.0M | — | $0 |
| FY2026 | $-5.2M | $-5.2M | — | $892.5K |